JESSICA DIGBY: Open Payments
NPI 1740247493 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 75 payments from 20 companies in 2025. Trend: 2023 $1,113 · 2024 $1,138 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $339 |
| AstraZeneca Pharmaceuticals LP | 8 | $128 |
| Lilly USA, LLC | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Madrigal Pharmaceuticals | 2 | $85 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| PFIZER INC. | 4 | $65 |
| Amgen Inc. | 4 | $60 |
| Corium, LLC | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
Products named: VRAYLAR, UBRELVY, Kerendia, REZDIFFRA, AIRSUPRA, JARDIANCE, Azstarys, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
